Veru Inc

NASDAQ:VERU USA Biotechnology
Market Cap
$38.68 Million
Market Cap Rank
#22683 Global
#8002 in USA
Share Price
$2.41
Change (1 day)
+1.69%
52-Week Range
$0.37 - $4.43
All Time High
$23.78
About

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosa… Read more

Veru Inc (VERU) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.166x

Based on the latest financial reports, Veru Inc (VERU) has a cash flow conversion efficiency ratio of -0.166x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.17 Million) by net assets ($37.12 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Veru Inc - Cash Flow Conversion Efficiency Trend (1990–2025)

This chart illustrates how Veru Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Veru Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Veru Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Veru Inc (1990–2025)

The table below shows the annual cash flow conversion efficiency of Veru Inc from 1990 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 $18.33 Million $-30.04 Million -1.639x -144.25%
2024-09-30 $32.32 Million $-21.68 Million -0.671x +85.00%
2023-09-30 $19.68 Million $-88.01 Million -4.473x -679.55%
2022-09-30 $82.80 Million $-47.51 Million -0.574x -461.16%
2021-09-30 $152.29 Million $-15.57 Million -0.102x -59.51%
2020-09-30 $30.11 Million $-1.93 Million -0.064x +62.22%
2019-09-30 $32.33 Million $-5.49 Million -0.170x +56.68%
2018-09-30 $29.48 Million $-11.55 Million -0.392x -2030.67%
2017-09-30 $48.45 Million $982.89K 0.020x +140.15%
2016-09-30 $33.93 Million $-1.71 Million -0.051x -8.09%
2015-09-30 $33.13 Million $-1.55 Million -0.047x -135.79%
2014-09-30 $28.07 Million $3.67 Million 0.131x -65.22%
2013-09-30 $31.40 Million $11.79 Million 0.376x -12.18%
2012-09-30 $24.22 Million $10.36 Million 0.428x +2.81%
2011-09-30 $16.75 Million $6.97 Million 0.416x +68.09%
2010-09-30 $16.13 Million $3.99 Million 0.247x -44.22%
2009-09-30 $12.95 Million $5.75 Million 0.444x +1.48%
2008-09-30 $9.71 Million $4.24 Million 0.437x +7842.94%
2007-09-30 $7.45 Million $-42.05K -0.006x -110.06%
2006-09-30 $4.77 Million $267.94K 0.056x +193.26%
2005-09-30 $3.31 Million $-199.26K -0.060x +49.30%
2004-09-30 $1.83 Million $-216.76K -0.119x -120.19%
2003-09-30 $493.13K $290.01K 0.588x +197.89%
2002-09-30 $630.28K $-378.65K -0.601x +94.97%
2001-09-30 $52.32K $-625.02K -11.945x -902.35%
2000-09-30 $-693.07K $-1.03 Million 1.489x +190.28%
1999-09-30 $1.72 Million $-2.84 Million -1.649x -75.79%
1998-09-30 $2.93 Million $-2.75 Million -0.938x +40.55%
1997-09-30 $3.55 Million $-5.61 Million -1.578x -192.58%
1996-09-30 $7.55 Million $-4.07 Million -0.539x +10.89%
1995-09-30 $7.60 Million $-4.60 Million -0.605x +0.17%
1994-09-30 $12.70 Million $-7.70 Million -0.606x -1403.54%
1993-09-30 $4.30 Million $200.00K 0.047x +112.79%
1992-09-30 $5.50 Million $-2.00 Million -0.364x -55.37%
1991-09-30 $4.70 Million $-1.10 Million -0.234x -583.69%
1990-09-30 $6.20 Million $300.00K 0.048x --